KTNA Studio – Dave Totten, artist

Photo by Deb Wessler

Photo by Dora Miller

KTNA Studio

KTNA On Air Studio, Jan 2013

Photo by Deb Wessler

Photo by James Trump

Winter Black-capped Chickadee

winter chickadee

Photo by Robin Song

Fish Lake morning

Fish Lake morning

photo: Robin Song

Archives

Morning Newscast – Thursday, July 1, 2010

by KTNA Staff ~ July 1st, 2010

KTNA’s morning news, weather, announcements, echos for July 1st.  Host is Sue Deyoe.  Headlines – Fishing closures for July 2nd; Denali State Park Trails get money for reconstruction; Denali Park raft company looking for stolen raft. (16 min)

Download Audio

Comments are closed.

http://rachelbrownphoto.com/cgh-68636/ Hra pharma, sa universities/institutes involved in uterine fibroids therapeutics development uterine fibroids therapeutics assessment assessment by monotherapy products assessment by route of administration assessment by molecule type late stage drug profiles acirceuroldquo companies esmya - drug profile product description mechanism of action rd progress upa-uf - drug profile product description mechanism of action rd progress late stage drug profiles acirceuroldquo universities/institutes mifepristone - drug profile product description mechanism of action rd progress mifepristone - drug profile product description mechanism of action rd progress misoprostol - drug profile product description mechanism of action rd progress discontinued products uterine fibroids - featured news jul 22, 2010: repros receives investigational review board approval to commence low dose for proellex study at icon site jun 11, 2010: fda lifts full clinical hold on repros' proellex may 19, 2010: preglem announces positive phase iii results of esmya for treatment of uterine fibroids apr 05, 2010: repros requests lift of clinical hold on proellex mar 06, 2010: preglem announces positive phase iii results for esmya oct 28, 2009: repros therapeutics announces amendment of nih proellex license aug 19, 2009: preglem provides an update on ulipristal acetate for the treatment of uterine fibroids aug 06, 2009: repros therapeutics inc. In more than 99 percent of fibroid cases, the tumors are benign (non-cancerous). In more than 99 percent of fibroid cases, the tumors are benign (non-cancerous). http://evanscourses.com/pdy-61253/ viagra 10 mg prezzo in farmacia A fibroma or myoma occurring especially on that occurs in the uterine wall. It could be weeks before any of the patients are in the clear. Further microarray analysis of tissue taken from women with fibroids revealed threefold higher levels of fas compared with normal myometrial tissue. All rights reserved. http://cgtargentinos.org/fqh-60526/ Who are at risk for uterine fibroids? There are various factors that can increase a woman's risk of developing fibroids. Sklare, ed. dennisaguyitt.com/qch-60409/ It could be weeks before any of the patients are in the clear. http://fernandobrome.es/qro-65218/